Literature DB >> 7176659

The measurement of urinary steroid glucuronides as indices of the fertile period in women. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, special programme of research, development and research training in human reproduction.

H Adlercreutz, J Brown, W Collins, U Goebelsman, A Kellie, H Campbell, J Spieler, G Braissand.   

Abstract

The concentrations of various estrogen glucuronides and pregnanediol-3 alpha-glucuronide have been measured in daily samples of early morning urine (EMU) and 24 h pooled collections throughout a total of 70 menstrual cycles (58 subjects). The immediate objective was to identify and assess the potential value of measuring hormone metabolites to locate the fertile period in women, with the ultimate aim of developing a non-invasive immunochemical test. The project was undertaken in five centres and the results showed that: (i) there was good agreement in the patterns and mean concentrations of metabolites between the centres; (ii) estrone-3-glucuronide should be the estrogen glucuronide selected for further study; (iii) the analysis of EMU provided information that was as useful as the corresponding measurements on pooled collections for 24 h; (iv) a rise in the concentration of estrone-3-glucuronide (50% over the mean of three preceding values) could be used to locate the start of the fertile period in greater than 90% of the ovarian cycles (from day LHmax -- 3 to day LHmax -- 7); attempts to locate the end of the fertile period by a threshold value or a defined rise in the level of pregnanediol-3 alpha-glucuronide were disappointing. A 50% rise over the mean of three preceding values in the derived concentration ratio of estrone-3-glucuronide/pregnanediol-3 alpha-glucuronide could be used to indicate the start of the fertile period, and a 50% decrease plus two days the start of the infertile period in greater than 80% of the ovarian cycles. The limitations, implications and future developments are discussed.

Entities:  

Keywords:  Examinations And Diagnoses; Fertile Period--indications; Laboratory Examinations And Diagnoses; Laboratory Procedures; Menstrual Cycle; Menstruation; Reproduction

Mesh:

Substances:

Year:  1982        PMID: 7176659     DOI: 10.1016/0022-4731(82)90573-8

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  5 in total

1.  Urinary sex steroid excretion levels during a soy intervention among young girls: a pilot study.

Authors:  Gertraud Maskarinec; Yukiko Morimoto; Rachel Novotny; Frank J Nordt; Frank Z Stanczyk; Adrian A Franke
Journal:  Nutr Cancer       Date:  2005       Impact factor: 2.900

2.  Hormonal Profiles of Menstrual Bleeding Patterns During the Luteal-Follicular Transition.

Authors:  Melanie H Jacobson; Penelope P Howards; James S Kesner; Juliana W Meadows; Celia E Dominguez; Jessica B Spencer; Lyndsey A Darrow; Metrecia L Terrell; Michele Marcus
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

3.  Usefulness of early morning urine estrone-3-glucuronide assay in the monitoring ovarian secretory function in precocious puberty.

Authors:  F Bassi; O Bartolini; A S Neri; R G Gheri; A Magini; S Bucciantini; V Bruni
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

4.  Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time.

Authors:  And Demir; Matti Hero; Henrik Alfthan; Amro Passioni; Juha S Tapanainen; Ulf-Håkan Stenman
Journal:  Hormones (Athens)       Date:  2022-05-26       Impact factor: 3.419

5.  The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention.

Authors:  L Bernstein; R K Ross; R A Lobo; R Hanisch; M D Krailo; B E Henderson
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.